Life sciences executives are entering the second half of 2026 with a split view of their industry: deep unease about the ...
Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results